Doug Jacobs is a primary care internal medicine resident physician and health policy researcher at Brigham and Women’s Hospital in Boston, Massachusetts. Doug received his M.D. with distinction at the University of California, San Francisco (UCSF), where he was also an Alpha Omega Alpha honors society inductee and a Bernard Osher Scholar. In 2015 he was awarded the Zuckerman Fellowship for public leadership to attend the Harvard T.H. Chan School of Public Health, where he received his M.P.H. degree. He graduated with honors from Brown University, receiving a Bachelor of Sciences in Human Biology.
Doug is the recent lead-author of a recent study published in the New England Journal of Medicine about adverse tiering of medications, and co-author of a recent study published in JAMA regarding access to specialists. This work was published in the New England Journal of Medicine and the Journal of the American Medical Association, and was covered by the New York Times, Washington Post, Forbes, CBS, Bloomberg, NPR, and others. He has since acted as an adviser to federal and state agencies regarding nondiscrimination policies, completing analyses to inform future regulations.
Recent Posts by Douglas Jacobs
HHS recently finalized regulations for the cornerstone non-discrimination provision of the ACA -- Section 1557. Health advocates and patient advocacy organizations lauded the final regulations, which expressly prohibit insurers from employing plan benefit designs or marketing practices that...
Under a proposed rule from CMS, insurers could elect---but are not required---to create a standardized option for sale on the exchange. How might standardization prevent discriminatory practices?
Section 1302 of the ACA regulates "adverse tiering," which some insurers use to discourage enrollment. However, the Section 1302 regulation has so far been limited, and new forms of discrimination have prompted many to call on the Obama Administration for a stronger response.
Insurers still have an incentive to discriminate, and some insurers are continuing to do so by making medications for those with chronic health conditions unaffordable. To prevent these discriminatory policies and others, it has become clear that the Obama administration needs to take a...